Journal of Neuroendocrinology, 2013
GLP-1 medications, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound), were originally developed for type 2 diabetes and later approved for chronic weight management at full therapeutic doses
Advanced Ergonomics : Our pens are designed for easy handling, ensuring that even patients with limited dexterity can administer doses safely
What a regulated treatment pathway should include Safe obesity treatment isn't just a prescription
Common experiences: slight increase in dream vividness, minor changes in sleep timing, occasional earlier awakening The first noticeable improvements often appear during this window
This is a difficult question to answer